Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms.

ABSTRACT:

SUBMITTER: Hobbs GS 

PROVIDER: S-EPMC5777196 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature